Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

PengYun Li

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Acta Pharmaceutica Sinica. B|February 13, 2026
Antibody‒drug conjugates with DHODH inhibitor as novel payload class for cancer and SARS-CoV-2 infection therapiesZhirui Liu, Lunzhi Yuan, Pengyun Li, et al.
Cell Death & Disease|June 17, 2020
Snail promotes the generation of vascular endothelium by breast cancer cellsZhenyu Chang, Yanan Zhang, Jie Liu, et al.
European Journal of Medicinal Chemistry|October 18, 2023
Discovery of highly potent and selective KRAS<sup>G12C</sup> degraders by VHL-recruiting PROTACs for the treatment of tumors with KRAS<sup>G12C</sup>-MutationNing Yang, Zhiya Fan, Shiyang Sun, et al.
Molecular Metabolism|October 1, 2016
Fibroblast activation protein (FAP) as a novel metabolic targetMiguel Angel Sánchez-Garrido, Kirk M Habegger, Christoffer Clemmensen, et al.
Bioorganic Chemistry|May 5, 2024
Exploration and structure-activity relationship research of benzenesulfonamide derivatives as potent TRPV4 inhibitors for treating acute lung injuryMengyuan Wang, Yuehao Zhang, Xu Cai, et al.
Oncology Research|October 6, 2025
Discovery and Characterization of Novel IKZF1/3 Glue Degraders against Multiple Hematological Cancer Cell LinesTing Wei, Pengli Wei, Yalei Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Potent and Selective IGF-IIR-Recruiting Bifunctional Molecules for Targeted Lysosomal Degradation of Extracellular and Membrane ProteinsYuan Zhao, Yaxian Liao, Pengyun Li, et al.
Journal of Medicinal Chemistry|July 16, 2025
Novel Highly Potent c-Met Degraders against a Broad Range of CancersChangkai Jia, Pengli Wei, Shiyang Sun, et al.
Journal of Medicinal Chemistry|August 1, 2025
Discovery of Novel Potent Triple IKZF1/2/3 Degraders for the Treatment of Hematological CancersTing Wei, Shiyang Sun, Xiaotong Hu, et al.
Journal of Hematology & Oncology|September 1, 2024
Novel potent molecular glue degraders against broad range of hematological cancer cell lines via multiple neosubstrates degradationPengyun Li, Xiaotong Hu, Zhiya Fan, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Acta Pharmaceutica Sinica. B|February 13, 2026
Antibody‒drug conjugates with DHODH inhibitor as novel payload class for cancer and SARS-CoV-2 infection therapiesZhirui Liu, Lunzhi Yuan, Pengyun Li, et al.
Cell Death & Disease|June 17, 2020
Snail promotes the generation of vascular endothelium by breast cancer cellsZhenyu Chang, Yanan Zhang, Jie Liu, et al.
European Journal of Medicinal Chemistry|October 18, 2023
Discovery of highly potent and selective KRAS<sup>G12C</sup> degraders by VHL-recruiting PROTACs for the treatment of tumors with KRAS<sup>G12C</sup>-MutationNing Yang, Zhiya Fan, Shiyang Sun, et al.
Molecular Metabolism|October 1, 2016
Fibroblast activation protein (FAP) as a novel metabolic targetMiguel Angel Sánchez-Garrido, Kirk M Habegger, Christoffer Clemmensen, et al.
Bioorganic Chemistry|May 5, 2024
Exploration and structure-activity relationship research of benzenesulfonamide derivatives as potent TRPV4 inhibitors for treating acute lung injuryMengyuan Wang, Yuehao Zhang, Xu Cai, et al.
Oncology Research|October 6, 2025
Discovery and Characterization of Novel IKZF1/3 Glue Degraders against Multiple Hematological Cancer Cell LinesTing Wei, Pengli Wei, Yalei Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Potent and Selective IGF-IIR-Recruiting Bifunctional Molecules for Targeted Lysosomal Degradation of Extracellular and Membrane ProteinsYuan Zhao, Yaxian Liao, Pengyun Li, et al.
Journal of Medicinal Chemistry|July 16, 2025
Novel Highly Potent c-Met Degraders against a Broad Range of CancersChangkai Jia, Pengli Wei, Shiyang Sun, et al.
Journal of Medicinal Chemistry|August 1, 2025
Discovery of Novel Potent Triple IKZF1/2/3 Degraders for the Treatment of Hematological CancersTing Wei, Shiyang Sun, Xiaotong Hu, et al.
Journal of Hematology & Oncology|September 1, 2024
Novel potent molecular glue degraders against broad range of hematological cancer cell lines via multiple neosubstrates degradationPengyun Li, Xiaotong Hu, Zhiya Fan, et al.
Pageof 12